EMV Capital PLC
LSE:EMVC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EMV Capital PLC
Cash from Operating Activities
EMV Capital PLC
Cash from Operating Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
EMV Capital PLC
LSE:EMVC
|
Cash from Operating Activities
-£1.4m
|
CAGR 3-Years
25%
|
CAGR 5-Years
8%
|
CAGR 10-Years
17%
|
|
|
Smith & Nephew PLC
LSE:SN
|
Cash from Operating Activities
$1.3B
|
CAGR 3-Years
40%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
LivaNova PLC
NASDAQ:LIVN
|
Cash from Operating Activities
$254.3m
|
CAGR 3-Years
54%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
12%
|
|
|
EKF Diagnostics Holdings PLC
LSE:EKF
|
Cash from Operating Activities
£9.7m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
|
Creo Medical Group PLC
LSE:CREO
|
Cash from Operating Activities
-£22.2m
|
CAGR 3-Years
5%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
|
Inspiration Healthcare Group PLC
LSE:IHC
|
Cash from Operating Activities
£4.4m
|
CAGR 3-Years
22%
|
CAGR 5-Years
6%
|
CAGR 10-Years
15%
|
|
EMV Capital PLC
Glance View
NetScientific Plc is a deep tech and life sciences venture capital investment company. The firm identifies, invests in, and builds high-growth companies in the United Kingdom and internationally. The company employs a capital-light investment approach, making use of its balance sheet and syndicating investments through its wholly owned VC subsidiary, EMV Capital Partners Limited. The company secures a mixture of direct equity stakes and carried interest stakes in its portfolio of companies, creating a structure that can support a large portfolio. The company develops customized, proactive investment strategies for its subsidiaries and portfolio companies. The firm has a portfolio of approximately 70 companies with a focus on life sciences, industrials, robotics & artificial intelligence (AI), and sustainability. Its subsidiaries include Glycotest, Inc., and ProAxsis Limited, among others.
See Also
What is EMV Capital PLC's Cash from Operating Activities?
Cash from Operating Activities
-1.4m
GBP
Based on the financial report for Jun 30, 2025, EMV Capital PLC's Cash from Operating Activities amounts to -1.4m GBP.
What is EMV Capital PLC's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
17%
Over the last year, the Cash from Operating Activities growth was 41%. The average annual Cash from Operating Activities growth rates for EMV Capital PLC have been 25% over the past three years , 8% over the past five years , and 17% over the past ten years .
